Physician profile
Jenna Roe
NPI 1235672080
$2,505.91
in general payments reported to CMS, 2019-2025
19 companies · $73.60 in 2025
The $73.60 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $351 · 2022: $126 · 2023: $489 · 2024: $1,466 · 2025: $73.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,222 · Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,222.10 |
| Food and Beverage | $806.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,772.14 | 2023-2024 | Venaseal |
| Abbvie INC. | $127.78 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $102.07 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $70.51 | 2021 | |
| Pfizer INC. | $55.39 | 2024-2025 | |
| Boston Scientific Corporation | $46.44 | 2025 | Varithena Administration Pack |
| Lilly USA, LLC | $36.39 | 2021 | |
| Abbott Laboratories | $35.11 | 2023 | Proclaim |
| Tactile Systems Technology INC | $35.10 | 2024 | Entre Plus, Flexitouch Plus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.24 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.11 | 2021 | |
| Astellas Pharma US INC | $28.96 | 2021 | |
| Eisai INC. | $24.65 | 2021 | |
| Allergan, INC. | $24.07 | 2022 | |
| Braintree Laboratories, INC. | $21.91 | 2023 | Sutab |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.66 | 2024 | Trelegy Ellipta |
| Merck Sharp & Dohme LLC | $15.52 | 2021 | |
| Novo Nordisk INC | $13.99 | 2021 | |
| Bardy Diagnostics, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Roe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.